user

Therapy with tenofovir in HBV/HIV co-infected patients with resistance or partial response to lamivudine

被引：0
|
作者：
Nunez, M [1 ]
Garcia-Samantego, J [1 ]
Perez-Olmeda, M [1 ]
Romero, M [1 ]
Rios, P [1 ]
Soriano, V [1 ]
机构：
[1] Hosp Carlos Madrid, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1892
引用
收藏
页码：636A / 636A
页数：1
相关论文
共 50 条
  • [1] Entecavir plus lamivudine as an alternative treatment for co-infected HBV/HIV patients with toxicity on tenofovir therapy
    Fontecha-Ortega, Maria
    Munoz-Mendoza, Vanesa
    Monsalvo, Marta
    Mateos, Marisa
    Angel Rodriguez-Sagrado, Miguel
    Gomez, Cristina
    Luis Casado, Jose
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [2] Entecavir safety and virological response in lamivudine- and tenofovir-experienced HBV/HIV co-infected patients
    Phillips, M. D.
    Ratcliffe, L.
    Pennell, A.
    Vilar, F. J.
    [J]. HIV MEDICINE, 2009, 10 : 31 - 31
  • [3] LONG-TERM EFFICACY OF LAMIVUDINE/EMTRICITABINE AND TENOFOVIR COMBINATION THERAPY ON HBV/HIV CO-INFECTED JAPANESE PATIENTS
    Kuzushita, Noriyoshi
    Suemura, Shigeki
    Toyama, Takashi
    Hasegawa, Hiroko
    Yuguchi, Kiyonori
    Sakakibara, Yuko
    Yoshio, Toshiyuki
    Nakazuru, Shoichi
    Yuki, Nobukazu
    Mita, Eiji
    [J]. HEPATOLOGY, 2010, 52 (04) : 552A - 552A
  • [4] Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients
    Punyawudho, Baralee
    Thammajaruk, Narukjaporn
    Thongpeang, Parawee
    Matthews, Gail
    Lewin, Sharon R.
    Burger, David
    Ruxrungtham, Kiat
    Avihingsanon, Anchalee
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (11) : 947 - 954
  • [5] Hepatitis B virus (HBV) response to therapy with lamivudine (LAM) and tenofovir (TFV) in HBV/HIv co-infected patients: Impact of genotype and treatment regimen.
    Jain, MK
    Comanor, L
    White, C
    Kipnis, P
    Elkin, C
    Leung, K
    Cantu, V
    Morgan, T
    Keiser, P
    Lee, WM
    [J]. HEPATOLOGY, 2004, 40 (04) : 673A - 673A
  • [6] Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV
    Benhamou, Y
    Bochet, M
    Tubiana, R
    Thibault, V
    Suffisseau, L
    Sullivan, M
    Rooney, J
    Brosgart, C
    Bricaire, F
    Katlama, C
    Poynard, T
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 138 - 138
  • [7] Low rate of delayed response in lamivudine experienced HIV/HBV co-infected patients treated with tenofovir disoproxil fumarate (TDF)
    Lada, O.
    Gervais, A.
    Branger, M.
    Peytavin, G.
    Colin, G.
    Fraqueiro, G.
    Males, S.
    Martinot-Peignoux, M.
    Matheron, S.
    Marcellin, P.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S259 - S259
  • [8] Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in the Gambia, West Africa
    Stewart B.
    Jobarteh M.L.
    Sarge-Njie R.
    Alabi A.
    De Silva T.
    Peterson K.
    Peterson I.
    Whittle H.
    Rowland-Jones S.
    Jaye A.
    Cotten M.
    Mendy M.
    [J]. BMC Research Notes, 4 (1)
  • [9] Wild type and YMDD variant of hepatitis B virus: No difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients
    de Vries-Sluijs, TEMS
    van der Eijk, AA
    Hansen, BE
    Osterhaus, ADME
    de Man, RA
    van der Ende, ME
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 (01) : 60 - 63
  • [10] Development of hepatitis B virus resistance for lamivudine in a Dutch cohort of HIV-HBV co-infected patients
    Wolters, LMM
    Niesters, HGM
    Brinkman, K
    Kroon, FP
    Richter, C
    Meenhorst, P
    de Man, RA
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 155 - 155
12345